Jump to content

MyBioSource

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Eagleash (talk | contribs) at 07:47, 22 February 2019 (Peer reviews: ref error msg). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
MyBioSource
Company typePublic
IndustryBiotech, Life Sciences, Manufacturing
Founded2007 (2007) in Vancouver, Canada
Headquarters,
Area served
Worldwide
Number of employees
20-25
Websitewww.mybiosource.com

MyBioSource, Inc. is a biotechnological products distribution company formed to create a large portfolio of laboratory research reagents, both hard to find and common items, with worldwide distributions. Backed by an elite network of laboratories and manufacturers, the company was launched in 2007 in Vancouver, British Columbia, Canada. Headquarters and operations were relocated to San Diego, United States.

Products

The company distributes a number of science reagents and assay kits, including custom recombinant proteins and antibodies, real time PCR and quantitative ELISA kits. The company's current catalog lists over 1 million individual products used in academic, biotechnological, and pharmaceutical industries.

Peer reviews

MyBioSource has been peer-reviewed in more than 200 scientific journals.[1]

Publications with MyBioSource products

  • Bak, M. J., Albrechtsen, N. W., Pedersen, J., Hartmann, B., Christensen, M., Vilsboll, T., Knop, F. K., Deacon, C. F., Dragsted, L. O., Holst, J. J. (2014) Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans. Eur J Endocrinology 170, 529-538 [2]
  • Dubuisson, O., Day, R. S., Dhurandhar, N. V. (2015) Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans. J Diabetes Complications 29, 83-87 [3]

References

  1. ^ [1]
  2. ^ "Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans". European Society of Endocrinology.
  3. ^ "Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans". Journal of Diabetes and Its Complications.